Healthcare provider profile · identity verified

Amanda H Stermer, MD

Family Practice · LE ROY, NY · NPI 1114306701

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	347	110
Levothyroxine Sodium	Levothyroxine Sodium	212	68
Omeprazole	Omeprazole	196	65
Amlodipine Besylate	Amlodipine Besylate	192	60
Metoprolol Succinate	Metoprolol Succinate	166	48
Lisinopril	Lisinopril	156	50
Gabapentin	Gabapentin	141	38
Losartan Potassium	Losartan Potassium	125	37
Rosuvastatin Calcium	Rosuvastatin Calcium	119	40
Albuterol Sulfate Hfa	Albuterol Sulfate	115	33
Metformin Hcl	Metformin Hcl	88	25
Trazodone Hcl	Trazodone Hcl	84	22
Hydrochlorothiazide	Hydrochlorothiazide	79	27
Furosemide	Furosemide	73	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	27
Duloxetine Hcl	Duloxetine Hcl	71	24
Fluticasone Propionate	Fluticasone Propionate	65	24
Pantoprazole Sodium	Pantoprazole Sodium	65	22
Alprazolam	Alprazolam	64	17
Metformin Hcl Er	Metformin Hcl	63	22
Eliquis	Apixaban	62	16
Famotidine	Famotidine	62	21
Simvastatin	Simvastatin	61	19
Tamsulosin Hcl	Tamsulosin Hcl	61	19
Hydroxyzine Hcl	Hydroxyzine Hcl	60	19
Alendronate Sodium	Alendronate Sodium	59	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	13
Carvedilol	Carvedilol	55	17
Torsemide	Torsemide	55	18
Mirtazapine	Mirtazapine	54	13
Venlafaxine Hcl Er	Venlafaxine Hcl	52	16
Bupropion Xl	Bupropion Hcl	51	11
Sertraline Hcl	Sertraline Hcl	49	15
Oxycodone Hcl	Oxycodone Hcl	48	22
Diclofenac Sodium	Diclofenac Sodium	47	13
Prednisone	Prednisone	47	34
Celecoxib	Celecoxib	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Ozempic	Semaglutide	45	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Allopurinol	Allopurinol	43	18
Lorazepam	Lorazepam	43	15
Escitalopram Oxalate	Escitalopram Oxalate	42	13
Montelukast Sodium	Montelukast Sodium	41	15
Potassium Chloride	Potassium Chloride	38	11
Spironolactone	Spironolactone	38	12
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Azithromycin	Azithromycin	36	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Irbesartan	Irbesartan	34	12
Cephalexin	Cephalexin	33	24
Warfarin Sodium	Warfarin Sodium	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	12
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	24
Pregabalin	Pregabalin	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Meloxicam	Meloxicam	28	12
Buspirone Hcl	Buspirone Hcl	27	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	27	23
Glipizide Er	Glipizide	26	suppressed
Methylprednisolone	Methylprednisolone	26	22
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Atenolol	Atenolol	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Finasteride	Finasteride	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Perphenazine	Perphenazine	19	suppressed
Baclofen	Baclofen	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Nystatin	Nystatin	18	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Amoxicillin	Amoxicillin	17	12
Ezetimibe	Ezetimibe	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Bumetanide	Bumetanide	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Enalapril Maleate	Enalapril Maleate	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	12	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Klor-Con	Potassium Chloride	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error